Accelerating progress toward the end of AIDS in India
The Union Conference 2022
Group photo of CIDI staff
We are CIDI
Chaisson headshot; USAID Awards Johns Hopkins Medicine, Partners, Up to $200 Million for Global TB R
1
2
3
4
5
January 31, 2023

The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV. 

November 8, 2022

CIDI researchers and faculty will join the virtual Union Conference--check out our agenda!

September 14, 2022

Did you miss CIDI’s Baltimore launch event? You can view the recorded proceedings!

September 9, 2022

We are excited to launch the Johns Hopkins Center for Infectious Diseases in India (CIDI). Our Center is established on a foundation of high impact, collaborative infectious disease research and education between Johns Hopkins and partnering Indian institutions that is decades long.  

August 4, 2022

To address the global burden of TB, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by USAID for the SMART4TB project.

DEVELOPMENTS NEWS ENGAGE
Vidya Mave and Sunil Solomon headshots

Dr. Vidya Mave and colleagues concluded considerable intrahost mycobacterium tuberculosis mutation rates were present at recurrence among patients with diabetes mellitus. 

Akshay Gupte

Dr. Akshay Gupte and team found females were 7 times more likely to have restrictive spirometry pattern and 22 times more likely to have preserved ratio impaired spirometry, compared with men.

Mehta and Lucas headshots

The findings by Drs. Shruti Mehta, Gregory Lucas and colleagues show population-specific interventions and routine surveillance are need to facilitate HIV elimination.

Vidya Mave

Dr. Vidya Mave discusses the pros and cons of shortened tuberculosis treatment with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ).

Accelerating progress toward the end of AIDS in India

The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV. 

Dr. Amita Gupta

TAG’s 2022 Research in Action Awards will honor activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C around the world. Check it out to see Amita Gupta, GKII Co-Chair, receive her award.

CIDI logo

CIDI and CCGHE-ID are accepting applications for a Sr. Grants & Contracts Analyst position. The position supports pre and post award grant activities, which have an ever-expanding domestic & international grants and contracts portfolio. 

Sunil Solomon

Sunil Solomon: “Each of us brings a different skill set... The coalition is focused on translating what all of us find for clinical relevance to make sure that whatever we are doing is tailored toward improving the public’s health.”

Amita Gupta headshot

Dr. Amita Gupta spoke to the Hindustan Times about the monkeypox outbreak. “Currently mass vaccination is not required. Instead, priority is recommended for contacts of cases..."